Skip to main content

Advertisement

SpringerLink
Log in

Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

The usefulness and prognostic impact of a pretherapeutic clinical staging is still a matter of discussion. However, a pretherapeutic estimation of the prognosis would be essential to adjust the patient's therapy. Our aim was to compare clinical and histopathological staging and to analyze the predictive value of routine clinical staging and its significance for the individualization of treatment.

Patients and methods

We analyzed the data of 368 patients treated with gastric cancer in the University of Heidelberg, Department of Surgery, from January 2001 to June 2009. Pretherapeutic parameters including sex, age, cTNM, grading, Laurén classification, tumor localization, as well as posttherapeutic parameters were analyzed, and their impact for survival was evaluated. Follow-up data was obtained for all patients (2.17% lost to follow-up).

Results

The overall accuracy was 64.1% for pT category, 54.5% for pN category, and 80.3% for M category for the primary resected patients. For the patients treated neoadjuvantly, the overall accuracy was 21.8% for the pT category, 58.0% for the pN category, and 80.0% for the M category. The prognosis was associated to the age (p = 0.017), tumor localization (p < 0.001), grading (p = 0.041), cT category (p < 0.001), cN category (p < 0.001), and cM category (p = 0.001). The multivariate analysis, including pre- and postoperative factors, revealed tumor localization (p = 0.002), cN category (p = 0.019), and metastatic lymph node rate (p < 0.001) as independent prognostic factors.

Conclusion

The accordance between clinical and histopathological staging is limited, but nevertheless pretherapeutic parameters have a high prognostic impact and could be used for individualized therapy planning. The relevant pretherapeutic prognostic factors can all be determined by routine clinical staging including CT and endoscopy. Consequently pretherapeutic prognostic evaluation and therapy planning seem to be feasible with routine staging methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roder J, Böttcher K, Siewert J, Busch R, Hermanek P, Meyer H (1993) Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992. Cancer 72(7):2089–2097

    Article  PubMed  CAS  Google Scholar 

  2. Siewert J, Böttcher K, Stein H, Roder J (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228(4):449–461

    Article  PubMed  CAS  Google Scholar 

  3. Ott K, Sendler A, Becker K, Dittler H, Helmberger H, Busch R, Kollmannsberger C, Siewert J, Fink U (2003) Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6(3):159–167. doi:10.1007/s10120-003-0245-4

    Article  PubMed  CAS  Google Scholar 

  4. Wilke H, Preusser P, Fink U, Gunzer U, Meyer H, Meyer J, Siewert J, Achterrath W, Lenaz L, Knipp H (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7(9):1318–1326

    PubMed  CAS  Google Scholar 

  5. Siewert J, Schuhmacher C, Fink U (1998) The German EORTC Study of neoadjuvant therapy of stomach carcinoma. Langenbecks Arch Chir Suppl Kongressbd 115:717–719

    PubMed  CAS  Google Scholar 

  6. Manner H, Rabenstein T, May A, Pech O, Gossner L, Werk D, Manner N, Günter E, Pohl J, Vieth M, Stolte M, Ell C (2009) Long-term results of endoscopic resection in early gastric cancer: the Western experience. Am J Gastroenterol 104(3):566–573. doi:10.1038/ajg.2008.151

    Article  PubMed  Google Scholar 

  7. Pohl J, Pech O, May A, Manner H, Ell C (2008) Endoscopic resection of early esophageal and gastric neoplasias. Dig Dis 26(4):285–290. doi:10.1159/000177010

    Article  PubMed  Google Scholar 

  8. Cunningham D, Allum W, Stenning S, Thompson J, Van de Velde C, Nicolson M, Scarffe J, Lofts F, Falk S, Iveson T, Smith D, Langley R, Verma M, Weeden S, Chua Y, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20. doi:10.1056/NEJMoa055531

    Article  PubMed  CAS  Google Scholar 

  9. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L, Italian Gastrointestinal Tumor Study Group (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg 230(2):170–178

    Article  PubMed  CAS  Google Scholar 

  10. Gouzi J, Huguier M, Fagniez P, Launois B, Flamant Y, Lacaine F, Paquet J, Hay J (1989) Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A french prospective controlled study. Ann Surg 209(2):162–166

    Article  PubMed  CAS  Google Scholar 

  11. Bonenkamp J, Hermans J, Sasako M, van de Velde C, Welvaart K, Songun I, Meyer S, Plukker J, Van Elk P, Obertop H, Gouma D, van Lanschot J, Taat C, de Graaf P, von Meyenfeldt M, Tilanus H, Group DGC (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914. doi:10.1056/NEJM199903253401202

    Article  PubMed  CAS  Google Scholar 

  12. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after d1 and d2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79(9–10):1522–1530. doi:10.1038/sj.bjc.6690243

    Article  PubMed  CAS  Google Scholar 

  13. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449. doi:10.1016/S1470-2045(10)70070-X

    Article  PubMed  Google Scholar 

  14. Hartgrink H, van de Velde C, Putter H, Bonenkamp J, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken J, Meijer S, Plukker J, van Elk P, Obertop H, Gouma D, van Lanschot J, Taat C, de Graaf P, von Meyenfeldt M, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11):2069–2077. doi:10.1200/JCO.2004.08.026

    Article  PubMed  CAS  Google Scholar 

  15. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K, Group JCO (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462. doi:10.1056/NEJMoa0707035

    Article  PubMed  CAS  Google Scholar 

  16. Wu C, Hsiung C, Lo S, Hsieh M, Chen J, Li A, Lui W, Whang-Peng J (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7(4):309–315. doi:10.1016/S1470-2045(06)70623-4

    Article  PubMed  CAS  Google Scholar 

  17. Bhandari S, Shim C, Kim J, Jung I, Cho J, Lee J, Lee M, Kim B (2004) Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc 59(6):619–626.

    Article  PubMed  Google Scholar 

  18. D'Elia F, Zingarelli A, Palli D, Grani M (2000) Hydro-dynamic ct preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 10(12):1877–1885

    Article  PubMed  Google Scholar 

  19. Habermann C, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, Dieckmann C, Schoder V, Adam G (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230(2):465–471. doi:10.1148/radiol.2302020828

    Article  PubMed  Google Scholar 

  20. Takao M, Fukuda T, Iwanaga S, Hayashi K, Kusano H, Okudaira S (1998) Gastric cancer: evaluation of triphasic spiral CT and radiologic–pathologic correlation. J Comput Assist Tomogr 22(2):288–294

    Article  PubMed  CAS  Google Scholar 

  21. Hundt W, Braunschweig R, Reiser M (1999) Assessment of gastric cancer: value of breathhold technique and two-phase spiral CT. Eur Radiol 9(1):68–72

    Article  PubMed  CAS  Google Scholar 

  22. Shimizu K, Ito K, Matsunaga N, Shimizu A, Kawakami Y (2005) Diagnosis of gastric cancer with MDCT using the water-filling method and multiplanar reconstruction: CT-histologic correlation. AJR Am J Roentgenol 185(5):1152–1158. doi:10.2214/AJR.04.0651

    Article  PubMed  Google Scholar 

  23. Chen C, Hsu J, Wu D, Kang W, Hsieh J, Jaw T, Wu M, Liu G (2007) Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic results. Radiology 242(2):472–482. doi:10.1148/radiol.2422051557

    Article  PubMed  Google Scholar 

  24. Hur J, Park M, Lee J, Lim J, Yu J, Hong Y, Kim K (2006) Diagnostic accuracy of multidetector row computed tomography in T- and N staging of gastric cancer with histopathologic correlation. J Comput Assist Tomogr 30(3):372–377.

    Article  PubMed  Google Scholar 

  25. Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T (1989) Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210(5):596–602

    Article  PubMed  CAS  Google Scholar 

  26. Kampschöer GH, Maruyama K, van de Velde CJ, Sasako M, Kinoshita T, Okabayashi K (1989) Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 76(9):905–908

    Article  PubMed  Google Scholar 

  27. Bollschweiler E, Boettcher K, Hoelscher AH, Sasako M, Kinoshita T, Maruyama K, Siewert JR (1992) Preoperative assessment of lymph node metastases in patients with gastric cancer: Evaluation of the Maruyama computer program. Br J Surg 79(2):156–160

    Article  PubMed  CAS  Google Scholar 

  28. Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ (2005) Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg 29(12):1576–1584. doi:10.1007/s00268-005-7907-9

    Article  PubMed  CAS  Google Scholar 

  29. Ott K, Herrmann K, Krause B, Lordick F (2008) The value of PET imaging in patients with localized gastroesophageal cancer. Gastrointest Cancer Res 2(6):287–294

    PubMed  Google Scholar 

  30. Stahl A, Ott K, Weber W, Becker K, Link T, Siewert J, Schwaiger M, Fink U (2003) FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 30(2):288–295. doi:10.1007/s00259-002-1029-5

    Article  PubMed  CAS  Google Scholar 

  31. Herrmann K, Ott K, Buck A, Lordick F, Wilhelm D, Souvatzoglou M, Becker K, Schuster T, Wester H, Siewert J, Schwaiger M, Krause B (2007) Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis. J Nucl Med 48(12):1945–1950. doi:10.2967/jnumed.107.044867

    Article  PubMed  CAS  Google Scholar 

  32. Becker K, Mueller J, Schulmacher C, Ott K, Fink U, Busch R, Böttcher K, Siewert J, Höfler H (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98(7):1521–1530. doi:10.1002/cncr.11660

    Article  PubMed  Google Scholar 

  33. Park S, Kim M, Ryu K, Lee J, Lee J, Nam B, Choi I, Kim Y (2010) Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg. doi:10.1097/SLA.0b013e3181cfd815

    Google Scholar 

  34. Johnson H, Belluco C, Masood S, Azama A, Kahn L, Wise L (1995) Preoperative factors of prognostic significance in gastric cancer. J Natl Med Assoc 87(6):423–426

    PubMed  CAS  Google Scholar 

  35. Kajiyama Y, Tsurumaru M, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M, Akiyama H (1997) Prognostic factors in adenocarcinoma of the gastric cardia: pathologic stage analysis and multivariate regression analysis. J Clin Oncol 15(5):2015–2021

    PubMed  CAS  Google Scholar 

  36. Barbour A, Rizk N, Gonen M, Tang L, Bains M, Rusch V, Coit D, Brennan M (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246(1):1–8. doi:10.1097/01.sla.0000255563.65157.d2

    Article  PubMed  Google Scholar 

  37. Kwee RM, Kwee TC (2007) Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 25(15):2107–2116. doi:10.1200/JCO.2006.09.5224

    Article  PubMed  Google Scholar 

  38. Lorenzen S, Panzram B, Rosenberg R, Nekarda H, Becker K, Schenk U, Höfler H, Siewert JR, Jäger D, Ott K (2010) Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol 17(10):2733–2739. doi:10.1245/s10434-010-1090-4

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Surgical Department, University Hospital Heidelberg, INF 110, Heidelberg, 69120, Germany

    Susanne Blank, Anja Schaible, Markus Buechler & Katja Ott

  2. Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany

    Hendrik Bläker

  3. Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany

    Lars Grenacher

  4. Third Medical Department (Hematology and Oncology), Klinikum Braunschweig, Brunswick, Germany

    Florian Lordick

  5. Hannover Medical School, Hannover, Germany

    Florian Lordick

Authors
  1. Susanne Blank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hendrik Bläker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anja Schaible
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Florian Lordick
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lars Grenacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Markus Buechler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katja Ott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katja Ott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blank, S., Bläker, H., Schaible, A. et al. Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbecks Arch Surg 397, 45–55 (2012). https://doi.org/10.1007/s00423-011-0805-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-011-0805-8

Keywords

Search

Navigation